Andere Sprachen Evaxion Biotech A/S

Aktien

A400P5

US29970R2040

EVAX

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 19.04.2024			% 5 Tage	% 1. Jan.
4,31 ^USD	+2,13 %		+5,12 %	-37,14 %

17.04.	Evaxion gibt Update zur klinischen Phase-2-Studie bekannt	CI
11.04.	Europäische Aktien, die in den USA als American Depositary Receipts gehandelt werden, fallen im Donnerstagshandel	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Evaxion Announces Phase 2 Clinical Trial Update	17.04.
Evaxion Announces Phase 2 Clinical Trial Update: First Patient Completed Dosing with Personalized Cancer Vaccine EVX-01	17.04.
European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading	11.04.
European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading	09.04.
European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading	08.04.
Certain Warrants of Evaxion Biotech A/S are subject to a Lock-Up Agreement Ending on 7-APR-2024.	07.04.
Certain American Depositary Shares of Evaxion Biotech A/S are subject to a Lock-Up Agreement Ending on 7-APR-2024.	07.04.
Certain Ordinary Shares of Evaxion Biotech A/S are subject to a Lock-Up Agreement Ending on 7-APR-2024.	07.04.
European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading, Close Out Week Lower	05.04.
European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading	03.04.
ADRs End Lower; Meta Data Slides 22%	02.04.
Sector Update: Health Care Stocks Slide Late Afternoon	02.04.
Sector Update: Health Care Stocks Slipping in Afternoon Trading	02.04.
Evaxion's EVX-B1 Vaccine Shows Promising Protection Against Staph Infections in Preclinical Studies; Shares Jump	02.04.
Evaxion and Undisclosed Collaborator Announce Encouraging Results for EVX-B1 Vaccine Antigens Against Staphylococcus Aureus Infection	02.04.
Evaxion and Undisclosed Collaborator Announce Encouraging Results for Evx-B1 Vaccine Antigens Against Staphylococcus Aureus Infection	02.04.
16 APRIL 2024 AT 15:00 (CEST) - Form 6-K	29.03.
European Equities Traded in the US as American Depositary Receipts Slightly Higher Thursday	28.03.
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Wednesday Trading	27.03.
Evaxion Announces Business Update and Full Year 2023 Financial Results	27.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Evaxion Biotech A/S

Aktien

A400P5

US29970R2040

EVAX

Andere Sprachen

Filter